Literature DB >> 10233730

Surface-expressed invariant chain (CD74) is required for internalization of human leucocyte antigen-DR molecules to early endosomal compartments.

G Moldenhauer1, C Henne, J Karhausen, P Möller.   

Abstract

Transport of major histocompatibility complex (MHC) class II molecules to the endocytic route is directed by the associated invariant chain (Ii). In the endocytic pathway, Ii is proteolytically cleaved and, upon removal of residual Ii fragments, class II alpha beta dimers are charged with antigenic peptide and recognized by CD4+ T cells. Although distinct peptide-loading compartments such as MIIC (MHC class II loading compartment) and CIIV (MHC class II vesicles) have been characterized in different cells, there is growing evidence of a multitude of subcellular compartments in which antigenic peptide loading takes place. We employed a physiological cellular system in which surface Ii (CD74) and surface human leucocyte antigen (HLA)-DR were induced either alone or in combination. This was achieved by transient exposure of HT-29 cells to recombinant interferon-gamma (rIFN-gamma). Using distinct cellular variants, we showed that: (i) the majority of Ii molecules physically associate on the cell membrane with class II dimers to form DR alpha beta:Ii complexes; (ii) the presence of surface Ii is a prerequisite for the rapid uptake of HLA-DR-specific monoclonal antibodies into early endosomes because only the surface DR+/Ii+ phenotype, and not the DR+/Ii- variant, efficiently internalizes; and (iii) the HLA-DR:Ii complexes are targeted to early endosomes, as indicated by co-localization with the GTPase, Rab5, and endocytosed bovine serum albumin. Internalization of HLA-DR:Ii complexes, accommodation of peptides by DR alphabeta heterodimers in early endosomes and recycling to the cell surface may be a mechanism used to increase the peptide repertoire that antigen-presenting cells display to MHC class II-restricted T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233730      PMCID: PMC2326754          DOI: 10.1046/j.1365-2567.1999.00676.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  54 in total

1.  Irreversible association of peptides with class II MHC molecules in living cells.

Authors:  A Lanzavecchia; P A Reid; C Watts
Journal:  Nature       Date:  1992-05-21       Impact factor: 49.962

2.  Constitutive endocytosis and recycling of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells.

Authors:  P A Reid; C Watts
Journal:  Immunology       Date:  1992-12       Impact factor: 7.397

3.  Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments.

Authors:  P Chavrier; R G Parton; H P Hauri; K Simons; M Zerial
Journal:  Cell       Date:  1990-07-27       Impact factor: 41.582

4.  Human major histocompatibility complex class II invariant chain is expressed on the cell surface.

Authors:  C J Wraight; P van Endert; P Möller; J Lipp; N R Ling; I C MacLennan; N Koch; G Moldenhauer
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

5.  Structural requirements for major histocompatibility complex class II invariant chain trafficking in polarized Madin-Darby canine kidney cells.

Authors:  G Odorizzi; I S Trowbridge
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

6.  Structure-activity relationship of the leucine-based sorting motifs in the cytosolic tail of the major histocompatibility complex-associated invariant chain.

Authors:  A Motta; B Bremnes; M A Morelli; R W Frank; G Saviano; O Bakke
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  A human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3).

Authors:  V Quaranta; O Majdic; G Stingl; K Liszka; H Honigsmann; W Knapp
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

8.  How MHC class II molecules reach the endocytic pathway.

Authors:  P Bénaroch; M Yilla; G Raposo; K Ito; K Miwa; H J Geuze; H L Ploegh
Journal:  EMBO J       Date:  1995-01-03       Impact factor: 11.598

9.  An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization.

Authors:  B Bremnes; T Madsen; M Gedde-Dahl; O Bakke
Journal:  J Cell Sci       Date:  1994-07       Impact factor: 5.285

10.  Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments.

Authors:  P A Warmerdam; E O Long; P A Roche
Journal:  J Cell Biol       Date:  1996-04       Impact factor: 10.539

View more
  9 in total

1.  HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Authors:  Roberto Meza-Romero; Gil Benedek; Xiaolin Yu; Jeffery L Mooney; Rony Dahan; Nerri Duvshani; Richard Bucala; Halina Offner; Yoram Reiter; Gregory G Burrows; Arthur A Vandenbark
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

2.  An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.

Authors:  Shi-Dong Ma; Xianming Yu; Janet E Mertz; Jenny E Gumperz; Erik Reinheim; Ying Zhou; Weihua Tang; William J Burlingham; Margaret L Gulley; Shannon C Kenney
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Gene expression in Atlantic salmon skin in response to infection with the parasitic copepod Lepeophtheirus salmonis, cortisol implant, and their combination.

Authors:  Aleksei Krasnov; Stanko Skugor; Marijana Todorcevic; Kevin A Glover; Frank Nilsen
Journal:  BMC Genomics       Date:  2012-04-05       Impact factor: 3.969

4.  Epstein-Barr virus evades CD4+ T cell responses in lytic cycle through BZLF1-mediated downregulation of CD74 and the cooperation of vBcl-2.

Authors:  Jianmin Zuo; Wendy A Thomas; Tracey A Haigh; Leah Fitzsimmons; Heather M Long; Andrew D Hislop; Graham S Taylor; Martin Rowe
Journal:  PLoS Pathog       Date:  2011-12-22       Impact factor: 6.823

5.  Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines.

Authors:  Hussain Al Ssadh; Waleed Al Abdulmonem
Journal:  Int J Health Sci (Qassim)       Date:  2019 Mar-Apr

6.  Interacting Effects of Sea Louse (Lepeophtheirus salmonis) Infection and Formalin-Killed Aeromonas salmonicida on Atlantic Salmon Skin Transcriptome.

Authors:  Albert Caballero-Solares; Navaneethaiyer Umasuthan; Xi Xue; Tomer Katan; Surendra Kumar; Jillian D Westcott; Zhiyu Chen; Mark D Fast; Stanko Skugor; Richard G Taylor; Matthew L Rise
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

7.  Hepatitis C virus-mediated inhibition of cathepsin S increases invariant-chain expression on hepatocyte surface.

Authors:  Hangeun Kim; Budhaditya Mazumdar; Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Daniel F Hoft; Ranjit Ray
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

Review 8.  The secret life of viral entry glycoproteins: moonlighting in immune evasion.

Authors:  Jonathan D Cook; Jeffrey E Lee
Journal:  PLoS Pathog       Date:  2013-05-16       Impact factor: 6.823

9.  Measurements of heterotypic associations between cluster of differentiation CD74 and CD44 in human breast cancer-derived cells.

Authors:  Hussain Al Ssadh; Patrick S Spencer; Waleed Alabdulmenaim; Rana Alghamdi; Inamul Hasan Madar; Jose M Miranda-Sayago; Nelson Fernández
Journal:  Oncotarget       Date:  2017-09-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.